Author:
Ionescu Sânziana,Radu Petre,Madge Octavia Luciana,Strâmbu Victor
Reference19 articles.
1. Kim NK, Hur H. New Perspectives on Predictive Biomarkers of Tumor Response and Their Clinical Application in Preoperative Chemoradiation Therapy for Rectal Cancer. Yonsei Med J. 2015 Nov;56(6):1461-77.
2. Liu SL, O’Brien P, Zhao Y, Hopman WM, Lamond N, Ramjeesingh R. Adjuvant treatment in older patients with rectal cancer: a population-based review. Curr Oncol. 2018 Dec;25(6):e499-e506.
3. Alecu M, Simion L, Straja N, Brătucu E. Multiple polyps and colorectal cancer. Chirurgia (Bucur). 2014 May-Jun;109(3):342-6. Available at: https://pubmed.ncbi.nlm.nih.gov/24956339/
4. Khakoo S, Carter PD, Brown G, Valeri N, Picchia S, Bali MA, Shaikh R, Jones T, Begum R, Rana I, Wotherspoon A, Terlizzo M, von Loga K, Kalaitzaki E, Saffery C, Watkins D, Tait D, Chau I, Starling N, Hubank M, Cunningham D. MRI Tumor Regression Grade and Circulating Tumor DNA as Complementary Tools to Assess Response and Guide Therapy Adaptation in Rectal Cancer. Clin Cancer Res. 2020 Jan 1;26(1):183-192.
5. Park YJ, Oh BR, Lim SW, Huh JW, Joo JK, Kim YJ, Kim HR. Clinical significance of tumor regression grade in rectal cancer with preoperative chemoradiotherapy. J Korean Soc Coloproctol. 2010 Aug;26(4):279-86.